SCHEMBL30709558

SCHEMBL30709558

Cc1ccc2c(c1)c1ccccc1n2-c1nc(-n2c3ccccc3c3cc(C)ccc32)c(-n2c3ccccc3c3cc(C)ccc32)c(-c2ccccc2-c2cc(C)nc(C)c2)c1-n1c2ccccc2c2cc(C)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.35
MEN1 O00255 1/20 0.32
NR1I2 O75469 1/20 0.32
AHR P35869 1/20 0.32
KMT2A Q03164 1/20 0.32
NTRK1 P04629 1/20 0.32
BCHE P06276 1/20 0.30
ACHE P22303 1/20 0.30
FLT3 P36888 1/20 0.30
NPY5R Q15761 1/20 0.30
PGR P06401 1/20 0.30
RORA P35398 1/20 0.30
RORC P51449 1/20 0.30
RORB Q92753 1/20 0.30
KDM4E B2RXH2 1/20 0.30
APAF1 O14727 1/20 0.30
MAPT P10636 1/20 0.30
PKM P14618 1/20 0.30
IDO1 P14902 1/20 0.30
MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22126317 0.96 PTGDR2 (0.35) PTGDR2MEN1NR1I2AHRKMT2A
SCHEMBL30709362 0.96 PTGDR2 (0.35) PTGDR2MEN1NR1I2AHRKMT2A
SCHEMBL30709450 0.88 MAPT (0.30) NPY5RMAPT
SCHEMBL30709611 0.88 DNMT1 (0.32) MEN1KMT2APGRRORARORC
SCHEMBL30709213 0.87 MEN1 (0.43) MEN1NR1I2AHRKMT2ANTRK1
SCHEMBL30709418 0.86 PTGER4 (0.37) RORCKDM4EMAPT
SCHEMBL30709191 0.84 CYP11B1 (0.40) KDM4EMAPTRAB9A
SCHEMBL30709248 0.84 NTRK1 (0.33) PTGDR2MEN1NR1I2AHRKMT2A
SCHEMBL30709422 0.84 MAOA (0.37) ACHENPY5R
SCHEMBL30709219 0.84 TOP2A (0.34) NPY5RIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 PTGDR2 1959/4885MEN1 2193/4885NR1I2 589/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.